BIG
PCVX icon

Brooklyn Investment Group’s Vaxcyte PCVX Stock Holding History

Brooklyn Investment Group’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$544K Buy
+9,370
New +$509K 0.02% 968
2025
Q3 		– Sell
-25
Closed -$782 – 2102
2025
Q2 		$782 Buy
25
+21
+525% +$688 ﹤0.01% 2993
2025
Q1 		$152 Sell
4
-6
-60% -$480 ﹤0.01% 2663
2024
Q4 		$819 Buy
+10
New +$993 ﹤0.01% 1647

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brooklyn Investment Group's PCVX Position: Q1 2026 in Review

Brooklyn Investment Group opened a new position in Vaxcyte (PCVX) in Q1 2026: 9,370 shares worth $544K. The stake represents 0.02% of the portfolio and ranks #968 among its holdings. This is a return to the name: Brooklyn Investment Group previously reported a position in PCVX as recently as Q2 2025.

Brooklyn Investment Group first reported a position in PCVX in Q4 2024 and has held it in 4 quarters since. 336 funds tracked by Wall St. Rank hold PCVX as of Q1 2026.

  • Brooklyn Investment Group held 9,370 shares of Vaxcyte worth $544K as of Q1 2026.
  • Vaxcyte was a new Brooklyn Investment Group position in Q1 2026.
  • Vaxcyte made up 0.02% of Brooklyn Investment Group's portfolio in Q1 2026, its #968 holding.
  • Brooklyn Investment Group first reported a position in Vaxcyte in Q4 2024 and has held it in 4 quarters since.
  • 336 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.